NVAX Novavax, Inc.
Healthcare$10.46+13.57%ClosedMarket Cap: $1.72B
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
2
Dispositions
0
Buy/Sell Ratio
0.00
Net Shares
+165,500
Shares Acquired
165,500
Shares Disposed
0
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue Apr 28 | Newton Charles W. | director | Sell | 9,520 | $0.00 | 19,040 |
| Thu Apr 16 | Walker Robert Edward | officer: EVP, R&D | Sell | 99,500 | $8.46 | 99,500 |
| Thu Apr 16 | Walker Robert Edward | officer: EVP, R&D | Sell | 66,000 | $0.00 | 6,600 |
| Thu Apr 16 | Walker Robert Edward | officer: EVP, R&D | Sell | 26,300 | $0.00 | 0 |
| Thu Apr 16 | Walker Robert Edward | officer: EVP, R&D | Sell | 22,510 | $10.11 | 0 |
| Thu Apr 16 | Walker Robert Edward | officer: EVP, R&D | Sell | 18,826 | $8.39 | 0 |
| Thu Apr 16 | Walker Robert Edward | officer: EVP, R&D | Sell | 11,500 | $6.97 | 0 |
| Thu Apr 16 | Walker Robert Edward | officer: EVP, R&D | Sell | 0 | $0.00 | 34,386 |
| Thu Mar 12 | Shiver John W. | director | Sell | 7,947 | $0.00 | 15,893 |
| Mon Mar 09 | O'Hara Elaine | officer: EVP, Chief Strategy Officer | Sell | 177,500 | $10.11 | 177,500 |
| Mon Mar 09 | Kelly James Patrick | officer: EVP, CFO and Treasurer | Sell | 12,223 | $0.00 | 136,503 |
| Mon Mar 09 | Kelly James Patrick | officer: EVP, CFO and Treasurer | Sell | 5,904 | $9.98 | 130,599 |
| Mon Mar 09 | Kelly James Patrick | officer: EVP, CFO and Treasurer | Sell | 194,000 | $10.11 | 194,000 |
| Mon Mar 09 | Jacobs John C | director, officer: President and CEO | Sell | 551,500 | $10.11 | 551,500 |
| Mon Mar 09 | Draghia-Akli Ruxandra | officer: EVP, Research & Development | Sell | 139,500 | $10.11 | 139,500 |